Table 10 Biphasic rapid and long-acting insulin analogs
From: Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society
Insulin aspart and protaminated (70%) + insulin aspart (30%) | NovoMix® 70/30 | Pre-mix with 70% long-acting insulin aspart (up to 24 hours) + 30% aspart insulin of immediate release, short acting (4-6 hours), to control post-prandial and interprandial glycemic levels |
Neutral protamine insulin lispro (75%) + insulin lispro (25%) | Humalog® Mix 25 | Pre-mix with 75% intermediate acting insulin NPL (up to 24 hours) + 25% insulin of immediate release, short-acting (4-5 hours), to control post-prandial and interprandial glycemic levels |
Neutral protamine insulin lispro (50%) + insulin lispro (50%) | Humalog® Mix 50 | Pre-mix with 50% intermediate acting insulin NPL (up to 24 hours) + 50% insulin of immediate release, short-acting (4-5 hours), to control post-prandial and interprandial glycemic levels |